
1. transplant proc. 2019 may;51(4):1157-1161. doi:
10.1016/j.transproceed.2019.01.089. epub 2019 feb 8.

overexpression mir-21 associated recurrence patients hepatitis
b virus-mediated hepatocellular carcinoma undergoing liver transplantation.

dundar hz(1), aksoy f(1), aksoy sa(2), tasar p(1), ugras n(3), tunca b(4), egeli 
u(4), cecener g(4), yerci o(3), kaya e(1).

author information: 
(1)general surgery, uludag university, bursa, turkey.
(2)medical biology, uludag university, bursa, turkey. electronic address:
secilak@uludag.edu.tr.
(3)pathology, uludag university, bursa, turkey.
(4)medical biology, uludag university, bursa, turkey.

liver transplantation (lt) best treatment option hepatitis b virus
(hbv)-mediated hepatocellular carcinoma (hcc). nevertheless, recurrence the
most important issue lt. aims present study evaluate the
relation dysregulated expression micrornas (mirnas) recurrence formation
in hbv-mediated hcc cases. total 42 hbv-mediated hcc patients evaluated
in study. among 21 mirnas, expression level mir-106a mir-21 
higher mir-143 mir145 lower patients hcc compared with
noncancerous liver tissues (p = .0388, p = .0214, p = .0321, p = .002,
respectively). compared nonrecurrent patients, expression level of
mir-21 3.54-fold higher mir-145 2.42-fold lower patients with
recurrence 5-year follow-up (p = .004 p = .032; respectively). 
addition, according multivariate cox regression analysis, overexpression
of mir-21 found prognostic indicator hbv-mediated hcc patients
(p = .002). conclusion, show significant association high
expression mir-21 recurrence hbv-mediated hcc. therefore, up-regulation
of mir-21 could serve promising prognostic marker hcc.

copyright © 2019 elsevier inc. rights reserved.

doi: 10.1016/j.transproceed.2019.01.089 
pmid: 31101191  [indexed medline]

